Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: A single-center experience

被引:13
作者
Adamson, R [1 ]
Obispo, E [1 ]
Dychter, S [1 ]
Dembitsky, W [1 ]
Moreno-Cabral, R [1 ]
Jaski, B [1 ]
Gordon, J [1 ]
Hoagland, P [1 ]
Moore, K [1 ]
King, J [1 ]
Andrews, J [1 ]
Rich, M [1 ]
Daily, PO [1 ]
机构
[1] Sharp Mem Heart Transplant Ctr, San Diego, CA USA
关键词
D O I
10.1016/S0041-1345(98)00171-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1107 / 1109
页数:3
相关论文
共 6 条
[1]  
CARRIER M, 1992, TRANSPLANT P, V24, P2586
[2]  
COSTANZONORDIN MR, 1989, J HEART TRANSPLANT, V8, P288
[3]   OKT3 MONOCLONAL-ANTIBODY IN CARDIAC TRANSPLANTATION - EXPERIENCE WITH 102 PATIENTS [J].
GAY, WA ;
OCONNELL, JG ;
BURTON, NA ;
KARWANDE, SV ;
RENLUND, DG ;
BRISTOW, MR .
ANNALS OF SURGERY, 1988, 208 (03) :287-290
[4]  
LADOWSKI JS, 1993, J CARDIOVASC SURG, V34, P135
[5]  
LASKE A, 1992, J HEART LUNG TRANSPL, V11, P357
[6]  
PULPON LA, 1990, TRANSPLANT P, V22, P2319